Slaughter and May advised Reckitt Benckiser Group plc on the establishment of an EMTN programme and subsequent issuances

Slaughter and May advised Reckitt Benckiser Group plc (“Reckitt”) on the establishment of a new £10,000,000,000 Euro Medium Term Note programme (the “Programme”). The Programme enables Reckitt Benckiser Treasury Services plc and Reckitt Benckiser Treasury Services (Nederland) B.V. to issue notes which will be guaranteed by Reckitt and admitted to trading on the Main Market of the London Stock Exchange.

Immediately following the establishment of the Programme, Slaughter and May additionally advised Reckitt on the following issuances:

- €650,000,000 3.625% Fixed Rate Senior Notes due 14 September 2028;
- €750,000,000 3.875% Fixed Rate Senior Notes due 14 September 2033; and
- £300,000,000 5.625% Fixed Rate Senior Notes due 14 December 2038.

Slaughter and May worked closely with Ambika Chauhan (Legal Director, CHQ Functions – Group Legal Affairs) throughout.

Reckitt is the company behind some of the world's most recognisable and trusted consumer brands in hygiene, health and nutrition, including Air Wick, Calgon, Cillit Bang, Clearasil, Dettol, Durex, Enfamil, Finish, Gaviscon, Harpic, Lysol, Mortein, Mucinex, Nurofen, Nutramigen, Strepsils, Vanish, Veet, Woolite and more.

Financing
Matthew Tobin Partner
Kevin Howes Partner
Adriana Bica Associate
Bianca Pereira Associate
Tax
Mike Lane Partner
Gabrielle Pereira Associate